The increased prevalence of S1PR2- and S1PR3- but not S1PR1-specific aAb in SSc-PAH patients may thus point towards an autoimmune-supported pathomechanism that could contribute to elevated pulmonary vascular resistance and the development of lung fibrosis in SSc-associated PAH. Here, S1PR2 is linked to systemic sclerosis.